What Metrics Matter For Wellchange Wct Stock Valuation Price At 2.70 Down 0.92 20260404 UK Government Urged to Proceed with ZeroHours Contract Ban Amid Business Opposition Analyst Target Prices for Raymond James Stock What Investors Should Know Italy Probes EasyJet Over Alleged Unfair Baggage Pricing on Booking Platforms SpaceX IPO Speculation Drives Surge in SpaceTheme Stocks and ETFs Japan Post Bank Share Price Doubles as Overseas Investors Diversify Beyond AI Traders Bet on IonQ Micron Anduril as Next Potential US Government Stake Targets Anteris Technologies Global Corp AVR Q1 2026 Earnings PreRevenue Biotech Posts WiderThanExpected Loss Stock Rallies on Pipeline Optimism AIFU Q3 2023 Earnings EPS Reported at 316 Shares Decline Amid Limited Disclosure Repay Holdings RPAY Q1 2026 Earnings EPS Beat Drives Strong PostMarket Rally Amphastar Pharmaceuticals AMPH Q1 2026 Earnings EPS Misses Estimates by Wide Margin Evolution Petroleum EPM Q1 2026 Earnings Massive EPS Miss Sends Shares Lower SOPH Q1 2026 Earnings EPS Misses Estimates as Revenue Remains Undisclosed Kura Oncology KURA Stages a Rally Testing Key Resistance at 12 LightWave Acquisition Corp LWAC Holds Steady at 1020 Amid Low Volume PepGen Inc PEPG Slips to 15 as Stock Navigates Key Support Zone Willow Lane Acquisition Corp II Unit WLIIU Holds Steady at 1018 as Resistance Level Becomes Key NAPCO Security Technologies NSSC Edges Lower Amid Consolidation Near Support KHC Q1 2026 Earnings Earnings Beat Boosts Sentiment Amid Revenue Uncertainty ADUS Q1 2026 Earnings EPS Beats Estimates by 242 Stock Edges Higher WORX Q3 2025 Earnings Net Loss Deepens as Stock Declines Sharply Arq Inc ARQ Q1 2026 Earnings NarrowerThanExpected Loss Drives Shares Higher RadNet Inc RDNT Q1 2026 Earnings EPS Misses Estimates Amid Operational Challenges COUR Q1 2026 Earnings EPS Falls Short of Estimates Amid Mixed Demand Signals Beyond Inc to Acquire Buy Buy Baby Brand Rights Reuniting Baby Retailer with Bed Bath Beyond EME Q1 2026 Earnings EPS Surges 1487 Above Estimates Stock Gains PharmaCyte Biotech PMCB Edges Higher SupportHolding Action at 081